These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23004340)

  • 21. Diadenosine polyphosphates activate a Ca(2+)-dependent K(+)-conductance in porcine aortic smooth muscle cells via P2-purinoceptors.
    Schlatter E; Gonska T; Windau J; Mehrens T
    Cell Physiol Biochem; 2000; 10(3):125-34. PubMed ID: 10878443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of Macrophage Inflammation by P2Y Purinergic Receptors.
    Klaver D; Thurnher M
    Cells; 2021 May; 10(5):. PubMed ID: 34064383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purinergic (P2) receptor control of lower genitourinary tract function and new avenues for drug action: an overview.
    Gur S; Kadowitz PJ; Hellstrom WJ
    Curr Pharm Des; 2007; 13(31):3236-44. PubMed ID: 18045173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P2-purinoceptor-mediated formation of inositol phosphates and intracellular Ca2+ transients in human coronary artery smooth muscle cells.
    Strøbaek D; Olesen SP; Christophersen P; Dissing S
    Br J Pharmacol; 1996 Aug; 118(7):1645-52. PubMed ID: 8842427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
    Yelovitch S; Camden J; Weisman GA; Fischer B
    J Med Chem; 2012 Jan; 55(1):437-48. PubMed ID: 22107038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emodin Inhibits ATP-Induced Proliferation and Migration by Suppressing P2Y Receptors in Human Lung Adenocarcinoma Cells.
    Wang X; Li L; Guan R; Zhu D; Song N; Shen L
    Cell Physiol Biochem; 2017; 44(4):1337-1351. PubMed ID: 29183030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyrimidinergic Receptor Activation Controls Toxoplasma gondii Infection in Macrophages.
    Moreira-Souza AC; Marinho Y; Correa G; Santoro GF; Coutinho CM; Vommaro RC; Coutinho-Silva R
    PLoS One; 2015; 10(7):e0133502. PubMed ID: 26192447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracellular Adenosine Diphosphate Ribose Mobilizes Intracellular Ca2+ via Purinergic-Dependent Ca2+ Pathways in Rat Pulmonary Artery Smooth Muscle Cells.
    Huang C; Hu J; Subedi KP; Lin AH; Paudel O; Ran P; Sham JS
    Cell Physiol Biochem; 2015; 37(5):2043-59. PubMed ID: 26584302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms.
    Rump LC; Oberhauser V; von Kügelgen I
    Kidney Int; 1998 Aug; 54(2):473-81. PubMed ID: 9690214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for requirement of tyrosine phosphorylation in endothelial P2Y- and P2U- purinoceptor stimulation of prostacyclin release.
    Bowden A; Patel V; Brown C; Boarder MR
    Br J Pharmacol; 1995 Nov; 116(6):2563-8. PubMed ID: 8590971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ontogeny of P2-purinoceptors in the longitudinal muscle and muscularis mucosae of the rat isolated duodenum.
    Brownhill VR; Hourani SM; Kitchen I
    Br J Pharmacol; 1997 Sep; 122(2):225-32. PubMed ID: 9313929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.
    Strassheim D; Verin A; Batori R; Nijmeh H; Burns N; Kovacs-Kasa A; Umapathy NS; Kotamarthi J; Gokhale YS; Karoor V; Stenmark KR; Gerasimovskaya E
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purinergic receptor agonists modulate phagocytosis and clearance of apoptotic cells in macrophages.
    Marques-da-Silva C; Burnstock G; Ojcius DM; Coutinho-Silva R
    Immunobiology; 2011; 216(1-2):1-11. PubMed ID: 20471713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P2 receptors in the murine gastrointestinal tract.
    Giaroni C; Knight GE; Ruan HZ; Glass R; Bardini M; Lecchini S; Frigo G; Burnstock G
    Neuropharmacology; 2002 Dec; 43(8):1313-23. PubMed ID: 12527481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling mechanisms mediating uridine adenosine tetraphosphate-induced proliferation of human vascular smooth muscle cells.
    Gui Y; He G; Walsh MP; Zheng XL
    J Cardiovasc Pharmacol; 2011 Dec; 58(6):654-62. PubMed ID: 21885991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative contribution of P2U- and P2Y-purinoceptors to endothelium-dependent vasodilatation in the golden hamster isolated mesenteric arterial bed.
    Ralevic V; Burnstock G
    Br J Pharmacol; 1996 Apr; 117(8):1797-802. PubMed ID: 8732294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors.
    Brown C; Tanna B; Boarder MR
    Br J Pharmacol; 1995 Nov; 116(5):2413-6. PubMed ID: 8581277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Responses of the aorta of the garter snake (Thamnophis sirtalis parietalis) to purines.
    Knight GE; Burnstock G
    Br J Pharmacol; 1995 Jan; 114(1):41-8. PubMed ID: 7712027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration.
    Pillois X; Chaulet H; Belloc I; Dupuch F; Desgranges C; Gadeau AP
    Circ Res; 2002 Apr; 90(6):678-81. PubMed ID: 11934835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase.
    Webb TE; Feolde E; Vigne P; Neary JT; Runberg A; Frelin C; Barnard EA
    Br J Pharmacol; 1996 Dec; 119(7):1385-92. PubMed ID: 8968547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.